4D Path
Cristiano Leao has extensive experience in the financial sector, currently serving as CFO and IR at 4D Path since June 2019. Prior roles include Partner and CRO at Cambridge Square Capital, Executive Director positions at Liquidity Finance LLP and BTG Pactual, and Managing Director at the Royal Bank of Scotland. Cristiano has also held the title of Director at BNP Paribas and UBS Investment Bank, specializing in EM Fixed Income Sales and EM Credit Trading. Additional experience includes director roles at Caboto Intesa BCI and extensive experience as Vice President at Paine Webber and Donaldson, Lufkin & Jenrette. Cristiano holds a B.A. in Engineering from Pontifícia Universidade Católica do Rio de Janeiro.
4D Path
4D Path specializes in integrating cancer diagnostics and precision medicine into a single quantitative digital platform based only on a single hematoxylin and eosin. Its patented technology is designed to be universal, with the ability to characterize underlying fundamental processes across cancer spectra in many organ systems.The company wasincorporated in 2016 and is based in Belmont, Massachusetts.